skip to main content
Refinado por: idioma: Russo remover The Lancet remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

Baselga, José, Dr ; Bradbury, Ian, PhD ; Eidtmann, Holger, MD ; Di Cosimo, Serena, MD ; de Azambuja, Evandro, MD ; Aura, Claudia, MD ; Gómez, Henry, MD ; Dinh, Phuong, MD ; Fauria, Karine, PhD ; Van Dooren, Veerle, MSc ; Aktan, Gursel, MD ; Goldhirsch, Aron, MD ; Chang, Tsai-Wang, MD ; Horváth, Zsolt, MD ; Coccia-Portugal, Maria, MD ; Domont, Julien, MD ; Tseng, Ling-Min, MD ; Kunz, Georg, MD ; Sohn, Joo Hyuk, MD ; Semiglazov, Vladimir, MD ; Lerzo, Guillermo, MD ; Palacova, Marketa, MD ; Probachai, Volodymyr, MD ; Pusztai, Lajos, DPhil ; Untch, Michael, PhD ; Gelber, Richard D, PhD ; Piccart-Gebhart, Martine, PhD

The Lancet (British edition), 2012-02, Vol.379 (9816), p.633-640 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

2
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

Bissler, John J, Prof ; Kingswood, J Christopher, FRCP ; Radzikowska, Elżbieta, MD ; Zonnenberg, Bernard A, MD ; Frost, Michael, MD ; Belousova, Elena, Prof ; Sauter, Matthias, MD ; Nonomura, Norio, Prof ; Brakemeier, Susanne, MD ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Chen, David, PhD ; Sahmoud, Tarek, MD ; Shah, Gaurav, MD ; Lincy, Jeremie, MS ; Lebwohl, David, MD ; Budde, Klemens, Prof

The Lancet (British edition), 2013-03, Vol.381 (9869), p.817-824 [Periódico revisado por pares]

Kidlington: Elsevier

Texto completo disponível

3
Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach
Material Type:
Artigo
Adicionar ao Meu Espaço

Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach

Brennan, Paul ; Hsu, Charles C ; Moullan, Norman ; Szeszenia-Dabrowska, Neonilia ; Lissowska, Jolanta ; Zaridze, David ; Rudnai, Peter ; Fabianova, Eleonora ; Mates, Dana ; Bencko, Vladimir ; Foretova, Lenka ; Janout, Vladimir ; Gemignani, Federica ; Chabrier, Amelie ; Hall, Janet ; Hung, Rayjean J ; Boffetta, Paolo ; Canzian, Federico

The Lancet (British edition), 2005-10, Vol.366 (9496), p.1558-1560 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

4
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

Bussel, James B, MD ; Provan, Drew, MD ; Shamsi, Tahir, MD ; Cheng, Gregory, MD ; Psaila, Bethan, MD ; Kovaleva, Lidia, MD ; Salama, Abdulgabar, MD ; Jenkins, Julian M, MSc ; Roychowdhury, Debasish, MD ; Mayer, Bhabita, MSc ; Stone, Nicole, PhD ; Arning, Michael, MD

The Lancet (British edition), 2009-02, Vol.373 (9664), p.641-648 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

5
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

Cleland, John GF, Prof ; Teerlink, John R, Prof ; Senior, Roxy, Prof ; Nifontov, Evgeny M, Prof ; Mc Murray, John JV, Prof ; Lang, Chim C, Prof ; Tsyrlin, Vitaly A, Prof ; Greenberg, Barry H, Prof ; Mayet, Jamil, MD ; Francis, Darrel P, MD ; Shaburishvili, Tamaz, MD ; Monaghan, Mark, PhD ; Saltzberg, Mitchell, MD ; Neyses, Ludwig, Prof ; Wasserman, Scott M, MD ; Lee, Jacqueline H ; Saikali, Khalil G, PhD ; Clarke, Cyril P, MBBS ; Goldman, Jonathan H, MD ; Wolff, Andrew A, MD ; Malik, Fady I, MD

The Lancet (British edition), 2011-08, Vol.378 (9792), p.676-683 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

6
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Material Type:
Artigo
Adicionar ao Meu Espaço

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Cortes, Javier, MD ; O'Shaughnessy, Joyce, MD ; Loesch, David, MD ; Blum, Joanne L, MD ; Vahdat, Linda T, MD ; Petrakova, Katarina, MD ; Chollet, Philippe, MD ; Manikas, Alexey, MD ; Diéras, Veronique, MD ; Delozier, Thierry, MD ; Vladimirov, Vladimir, MD ; Cardoso, Fatima, MD ; Koh, Han, MD ; Bougnoux, Philippe, MD ; Dutcus, Corina E, MD ; Seegobin, Seth, MSc ; Mir, Denis, MSc ; Meneses, Nicole, MSHS ; Wanders, Jantien, MD ; Twelves, Chris, Prof

The Lancet (British edition), 2011-03, Vol.377 (9769), p.914-923 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

7
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Material Type:
Artigo
Adicionar ao Meu Espaço

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

Dalton, Tracy, Dr ; Cegielski, Peter, MD ; Akksilp, Somsak, MD ; Asencios, Luis, MPH ; Caoili, Janice Campos, MD ; Cho, Sang-Nae, Prof ; Erokhin, Vladislav V, MD ; Ershova, Julia, PhD ; Gler, Ma Tarcela, MD ; Kazennyy, Boris Y, MD ; Kim, Hee Jin, MD ; Kliiman, Kai, MD ; Kurbatova, Ekaterina, MD ; Kvasnovsky, Charlotte, MD ; Leimane, Vaira, MD ; van der Walt, Martie, PhD ; Via, Laura E, PhD ; Volchenkov, Grigory V, MD ; Yagui, Martin A, MD ; Kang, Hyungseok, MD

The Lancet (British edition), 2012-10, Vol.380 (9851), p.1406-1417 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

8
Quality of hospital care for children in Kazakhstan, Republic of Moldova, and Russia: systematic observational assessment
Material Type:
Artigo
Adicionar ao Meu Espaço

Quality of hospital care for children in Kazakhstan, Republic of Moldova, and Russia: systematic observational assessment

Duke, Trevor ; Keshishiyan, Elena ; Kuttumuratova, Aigul ; Ostergren, Mikael ; Ryumina, Irina ; Stasii, Ekaterina ; Weber, Martin W ; Tamburlini, Giorgio

The Lancet (British edition), 2006-03, Vol.367 (9514), p.919-925 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

9
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

Forette, Françoise ; Seux, Marie-Laure ; Staessen, Jan A ; Thijs, Lutgarde ; Birkenhäger, Willem H ; Babarskiene, Marija-Ruta ; Babeanu, Speranta ; Bossini, Alfredo ; Gil-Extremera, Blas ; Girerd, Xavier ; Laks, Tovio ; Lilov, Emil ; Moisseyev, Valentine ; Tuomilehto, Jaakko ; Vanhanen, Hannu ; Webster, John ; Yodfat, Yair ; Fagard, Robert

The Lancet (British edition), 1998-10, Vol.352 (9137), p.1347-1351 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

10
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

Franz, David Neal, Prof ; Belousova, Elena, MD ; Sparagana, Steven, MD ; Bebin, E Martina, MD ; Frost, Michael, MD ; Kuperman, Rachel, MD ; Witt, Olaf, MD ; Kohrman, Michael H, MD ; Flamini, J Robert, MD ; Wu, Joyce Y, MD ; Curatolo, Paolo, Prof ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Thiele, Elizabeth A, MD ; Ford, James P, MS ; Shah, Gaurav, MD ; Cauwel, Helene, MSc ; Lebwohl, David, MD ; Sahmoud, Tarek, MD ; Jozwiak, Sergiusz, MD

The Lancet (British edition), 2013-01, Vol.381 (9861), p.125-132 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Buscando em bases de dados remotas. Favor aguardar.